Editorial Questions or questions about the Editorial Calendar? Contact Patricia Van Arnum, DCAT’s Editorial Director at [email protected], Tel: +1-(856)-388-2964
Interested in advertising? See here to request the DCAT Value Chain Insights Media Kit or for questions, contact the DCAT Sponsorship Team at [email protected].
2026 Editorial Calendar (Balance of 2026 Editorial Calendar: October–December 2026, see here).
2027 Editorial Calendar (see below).
Production to Prescription podcast series: see here for the 2026 episodes and upcoming 2026 schedule and here for the 2027 schedule.
2027 Editorial Calendar
Content themes:
- Bio/Pharma Industry Radar
Top trends impacting the global bio/pharmaceutical industry and its manufacturing value chain. - CDMO/CMO and Supplier Report
Key developments from CDMOs/CMOs and suppliers, along with trends shaping outsourcing and pharma ingredients supply. - Manufacturing and Supply Lines
The latest developments impacting the industry’s manufacturing value chain, from raw materials to drug substances (small molecules & biologics) to drug products to packaging. - Executive Insights
Industry leaders share their perspectives on drug development, commercialization, manufacturing, and supply. - Special Reports
Coverage of DCAT webinars and educational programs, including those from DCAT Week and other industry-focused reports.
DCAT Value Chain Insights 2027 Editorial Calendar: January-December 2027
| Issue Date |
Content Focus |
| January 8 |
Bio/Pharma Industry Radar: Outlook for 2027 Experts weigh in on the top issues impacting the bio/pharma industry in 2027. |
| January 15 |
The CDMO/CMO & Supplier Report: The Year Ahead Market outlook for bio/pharmaceutical outsourcing in 2027. |
| January 22 |
Manufacturing & Supply Lines:
Small Molecules Global update on manufacturing investments for small-molecule drugs. |
| January 29 |
Executive Insights: Biomanufacturing The latest manufacturing trends for biologics. |
| February 5 |
Bio/Pharma Industry Radar: Blockbuster Potential The leading pipeline contenders expected to launch in 2027. |
| February 12 |
The CDMO/CMO & Supplier Report: Parenteral Drugs Analysis of manufacturing capacity in sterile manufacturing and aseptic fill–finish. |
| February 19 |
Special Report: DCAT Week 2027 Preview A preview of the education programs at DCAT Week 2027 (March 15–18, 2027). |
| February 26 |
Special Report: DCAT Week 2027 Preview A preview of the education programs at DCAT Week 2027 (March 15–18, 2027). |
| March 5 |
No issue (DCAT Week, March 15–18, 2027). |
| March 12 |
No issue (DCAT Week, March 15–18, 2027). |
| March 19 |
No issue (DCAT Week, March 15–18, 2027). |
| March 26 |
DCAT Week 2027 in Review Key takeaways from the education programs at DCAT Week 2027. |
| April 2 |
Bio/Pharma Industry Radar: ESG & Sustainability Key initiatives in advancing environmental performance, including greenhouse gas reductions. |
| April 9 |
The CDMO/CMO & Supplier Report: Solid Dosage Drugs The latest market and technology trends for solid-dosage drugs. |
| April 16 |
Manufacturing & Supply Lines: Fine Chemicals & Pharma Ingredients Executive insights on global supply chains for fine chemicals and pharma ingredients. |
| April 23 |
Executive Insights: Europe The latest market, supply chain, and policy moves impacting the pharma industry in Europe. |
| April 30 |
Special Report: Generics/Biosimilars Outlook Market outlook for generic drugs and biosimilars. |
| May 7 |
Bio/Pharma Industry Radar: Orphan Drugs Market overview of the top-selling and blockbuster contenders for rare-disease drugs. |
| May 14 |
The CDMO/CMO & Supplier Report: TIDES The latest expansions among CDMOs/CMOs in peptides and oligonucleotides and key market trends. |
| May 21 |
Manufacturing & Supply Lines:
AI in Pharma Manufacturing
Executive roundtable on the current & future use of AI in pharmaceutical manufacturing. |
| May 28 |
No issue |
| June 4 |
Bio/Pharma Industry Radar: The Top Deals & Dealmakers Analysis of the top deals in the bio/pharma industry thus far in 2027. |
| June 11 |
The CDMO/CMO & Supplier Report: Mid-Year Review The key trendsimpacting the CDMO/CMO sector thus far in 2027. |
| June 18 |
Manufacturing & Supply Lines:
Big Pharma Manufacturing Roundup
Global update on manufacturing investments of the bio/pharma majors. |
| June 25 |
Executive Insights: New Modalities Executives weigh in on the top product innovations. |
| July 2 |
No issue |
| July 9 |
Bio/Pharma Industry Radar: Small-Molecule APIs Analysis of the top-selling small-molecule drugs and pipeline contenders. |
| July 16 |
The CDMO/CMO & Supplier Report: Packaging The latest trends and innovation in primary packaging. |
| July 23 |
Manufacturing & Supply Lines: Digitalization, Data Integrity & Cybersecurity Senior executives share perspectives on the use of digitalization in managing global supply chains. |
| July 30 |
Executive Insights: Biomanufacturing Executive insights on manufacturing trends for biologics. |
| August 6 |
Bio/Pharma Industry Radar: Emerging Pharma The Emerging Pharma companies on the industry’s radar. |
| August 13 |
The CDMO/CMO & Supplier Report: AI How CDMOs are applying AI in their operations—manufacturing and supply management. |
| August 20 |
Manufacturing & Supply Lines: Cell & Gene Therapies A roundup of manufacturing investments in cell & gene therapies by CDMOs/CMOs and pharma companies. |
| August 27 |
No issue |
| September 3 |
Bio/Pharma Industry Radar: The Innovation Leaders Companies rising to the top with product innovation. |
| September 10 |
The CDMO/CMO & Supplier Report: Injectables Executive insights on manufacturing and technology trends for injectable drugs. |
| September 17 |
Manufacturing & Supply Lines: Continuous Manufacturing Advances in flow chemistry and continuous manufacturing for drug substances. |
| September 24 |
Executive Insights: Supplier Relationship Management Industry perspectives on optimizing the pharma customer-supplier relationship. |
| October 1 |
Bio/Pharma Industry Radar: Small-Molecule APIs Analysis of the top-selling small-molecule drugs and pipeline contenders. |
| October 8 |
The CDMO/CMO & Supplier Report: ADCs & Other Complex Conjugates Market trends and the latest developments in ADCs & other complex conjugates. |
| October 15 |
Manufacturing & Supply Lines: Excipients & Drug Products Key market & technology trends in excipients and drug products. |
| October 22 |
Executive Insights: The Innovation Leaders Executive roundtable on what is driving innovation across the bio/pharmaceutical industry. |
| October 29 |
Special Report: New Modalities Market and pipeline outlook for new modalities. |
| November 5 |
Bio/Pharma Industry Radar: The Pipeline Contenders Analysts weigh in on leading late-stage drug candidates with strong market potential. |
| November 12 |
The CDMO/CMO & Supplier Report: Global API Outlook Supply-demand fundamentals and global outlook for active pharmaceutical ingredients. |
| November 19 |
Manufacturing & Supply Lines: Biomanufacturing The latest expansions and trends in contract manufacturing. |
| November 26 |
No issue |
| December 3 |
Bio/Pharma Industry Radar: The Year in Review A look at the top developments in the bio/pharma industry in 2027. |
| December 10 |
The CDMO/CMO & Supplier Report: The Movers & Shakers of 2027 A look at the top moves from CDMOs/CMOs in 2027. |
| December 17 |
Manufacturing & Supply Lines: Manufacturing Innovation Key manufacturing innovation in the bio/pharma industry in 2027. |
| December 24 |
No issue |
| December 31 |
No issue |
